Avec un nombre croissant de cas positifs de COVID-19 qui continuent d'augmenter quotidiennement dans plusieurs pays africains, tandis que d'autres relèvent les défis d'une ouverture en toute sécurité de leurs économies après un verrouillage, la difficulté des conséquences économiques de la pandémie se fait sentir dans tous les pays. Cet impact économique, dans certains pays, a été pire que les conséquences immédiates de la pandémie et pourrait avoir un impact durable sur le secteur de la santé. Ainsi, il est important de noter que, tout en faisant face à l'évolution des taux d'admission à l'hôpital et d'exposition, de nombreux prestataires de soins de santé sont confrontés à la réalité économique du traitement ou de l'admission des cas de COVID-19. Il s'agit souvent d'un accès limité au dépistage, tout en devant traiter d'autres problèmes de santé critiques tels que le paludisme, la tuberculose, le VIH/SIDA,
et l'augmentation des maladies non transmissibles telles que le diabète et ses complications, l'hypertension et ses complications, les cancers.
People to People, Inc. (P2P) et Anadach Group vous invitent par la présente à participer à la septième session de notre série de webinaires « Briser le cercle vicieux entre la pandémie de COVID-19 et d'autres problèmes de santé, et l'impact négatif sur l'économie », provenant de pays plus tôt touchés par la pandémie que la plupart des pays africains. L'objectif de ces webinaires est de partager l'expérience clinique et de gestion et de créer une plate-forme permettant aux professionnels de la santé d'interagir sur la gestion clinique et les questions connexes dans plusieurs domaines.
Le spectre clinique du COVID-19 varie des formes asymptomatiques ou pauci-symptomatiques, aux états cliniques caractérisés par une insuffisance respiratoire, pouvant nécessiter une ventilation mécanique et une prise en charge en réanimation, aux manifestations multi-organiques et systémiques en termes de sepsis, choc septique, et les syndromes de dysfonctionnement de plusieurs organes (MODS). En réponse à COVID-19, les pays du monde entier ont mis en place une série de mesures de santé publique et sociales, qui sont des actions d'individus, d'institutions, de communautés, de gouvernements locaux et nationaux, et
organismes internationaux, pour supprimer ou arrêter la propagation communautaire du COVID-19.
La réponse efficace à la pandémie qui comprenait des mesures de distanciation sociale dans de nombreux pays a entraîné des ralentissements économiques importants affectant tous les secteurs de l'économie, y compris l'agriculture, les services financiers, l'éducation, etc. Cela a également été exacerbé par le déclin économique synchronisé à travers le monde affectant les partenaires commerciaux, et l'effondrement de la demande de matières premières, de services et de produits. Selon la Banque mondiale, « la pandémie met en péril les progrès de la décennie dans le renforcement du capital humain, y compris les améliorations de la santé, les taux de survie, la scolarisation et la réduction du retard de croissance ». Cependant, ce déclin du capital humain pourrait également interrompre de manière significative l'histoire de « l'African Rising » du 21e siècle.
Ce webinaire discutera des mesures pratiques pour réduire l'impact économique négatif sur la santé des Africains, et de l'importance de réduire tout autre impact négatif sur l'état de santé et les systèmes de prestation de soins de santé.
Veuillez vous inscrire pour participer. Et partagez avec vos collègues concernés. Merci.
https://us02web.zoom.us/meeting/register/tZUucu2urj8rGtTAVFK-iYGmz5AqG07DKa_t
Notre série de webinaires couvre des questions d'intérêt pour les médecins, les infirmières, les autres travailleurs de la santé et la direction impliqués dans la gestion directe des cas de COVID-19 dans leurs pays respectifs. La plupart des spécialistes exerçant hors d'Afrique ont également une expérience de la pratique médicale dans au moins un pays africain. L'enregistrement des webinaires et présentations précédents est disponible sur :
https://www.anadach.com/covid19serieswebinarindex
Panélistes
Dr Yele Aluko - Médecin-chef pour le secteur consultatif de la santé d'EY Amériques. - Télécharger la présentation
Dr Babatunde Omilola - Division de la santé publique, de la sécurité et de la nutrition de la Banque africaine de développement (BAD).
M. Gyude Moore , Senior Policy Fellow, Center for Global Development, et ancien ministre des Travaux publics du Libéria
Professeur Mammo Muchie, professeur de recherche DST/NRF sur la science, la technologie et l'innovation pour le développement à l'Université de technologie de Tshwane, Afrique du Sud
Professeur Lemma W. Senbet - Chaire William E. Mayer Professeur de finance à la Smith School de l'Université du Maryland, College Park ; Directeur du Centre de politique financière.
Dr Amit Thakker - Président exécutif, Africa Health Business ; Président, Fédération Africaine de la Santé ; Président, Kenya Healthcare Federation (Modérateur) - Télécharger la présentation
Dr Feseha Woldu , Vice-président pour les programmes de population et les affaires communautaires, MedStar Health, Washington DC (Modérateur)
Dr. Yele Aluko
Panelist
Dr. Yele Aluko is the Chief Medical Officer for EY Americas Advisory Health Sector. He is a proven MD/MBA physician executive and corporate leader. Also, he advises health system C-suite executives on strategies that position the business for operational efficiency, successful financial performance and enterprise growth, driven by transformational leadership and the delivery of stakeholder value.
Prior to joining EY in October 2016, Dr. Aluko practiced interventional cardiology for 25 years in clinical and administrative leadership roles. He trained at the College of Physicians and Surgeons of Columbia University, and he did cardiology fellowships at Cornell University Medical Center and the University of Massachusetts Medical Center. He obtained his MBA from Wake Forest University School of Business.
Dr. Babatunde Omilola
Panelist
Dr. Babatunde Omilola is currently leading the Public Health, Security and Nutrition Division of the African Development Bank (AfDB).
A development economist and international development expert, he previously served as Head of Development Planning and Inclusive Sustainable Growth at UNDP in New York, where he led a team of professionals on development planning, social protection, poverty, inequality, development finance, inclusive growth and the SDGs. He was UNDP’s Regional Practice Leader for poverty reduction and the achievement of the MDGs for the 23 Eastern and Southern African countries and UNDP’s Chief Economist and Head of Policy and Strategy in South Africa.
Dr. Omilola was Africa-wide Coordinator and Program Leader of the Regional Strategic Analysis and Knowledge Support System with the International Food Policy Research Institute (IFPRI), Washington D.C. He handled the relationship of the Food and Agriculture Organization of the United Nations (FAO) with the African Union Commission (AU) and the United Nations Economic Commission for Africa (ECA) in Addis Ababa, Ethiopia. He was also a research fellow on a collaborative Anti-poverty Programme between the International Water Management Institute (IWMI), the New Partnership for Africa’s Development (NEPAD), the International Fund for Agricultural Development (IFAD), AfDB, FAO and the World Bank.
Dr. Omilola has received a number of awards for his work in development. In 2014, he was selected as a Fellow of Comparative Research Programme for preventing and eradicating poverty. He holds an M.Phil. and a Ph.D. in International Development and Development Economics respectively from the Institute of Development Studies (IDS), University of Sussex, United Kingdom. He won the prestigious Ford Foundation International Fellowship in 2001 and the Graduate Research Fellowship of the International Development Research Centre (IDRC), Canada in 2004.
Professor Lemma Senbet
Panelist
Lemma W. Senbet is the William E. Mayer Chair Professor of Finance at the Smith School of the University of Maryland, College Park and Director of the Center for Financial Policy. He is also the incoming Executive Director of the African Economic Research Consortium (AERC). He has been an influential member of the global community of finance scholars for over 30 years. His chief research interests are in the areas of corporate finance, international finance, agency, and financial contracting. He has advised the World Bank, the International Monetary Fund, the United Nations, African Economic Research Consortium, and other international institutions on issues of financial sector reform and capital market development. He also served as an independent director for The Fortis Funds and currently is an independent director for The Hartford Funds.
Professor Senbet has received numerous professional honors and recognitions for his impact on the finance profession. He has been elected (twice) director of the American Finance Association and is a past president of the Western Finance Association. He has served on more than a dozen journal editorial boards, including extended tenures with the Journal of Finance, Journal of Financial and Quantitative Analysis, and Financial Management. In 1999, he was named executive editor of Financial Management. In 2006, he was named Editor (Finance Area) for Journal of
International Business Studies.
Dr. Amit Thakker
Moderator
A visionary entrepreneur & an industry captain, Dr. Amit N. Thakker, has been a groundbreaking pioneer in the integration of private sector within the health system in Africa.
He is the Executive Chairman of Africa Health Business, President of Africa Healthcare Federation, Chairman of the Kenya Healthcare Federation and currently serves as a Director with AMREF Flying Doctors (Kenya), LumiraDx & Ghanima Limited. Amit is an active member of several institutions including international business group YPO Gold at the Nairobi Chapter, Chairs the University of Nairobi Alumni Medical Chapter, & sits as an advisor to Eastern Africa Association as well as to Asia Africa Investing & Consulting ltd
Dr. Thakker founded Avenue Healthcare, a Kenyan based integrated private health service provider in 1995 which led him to receive the “Best Male Entrepreneur of the year” award by Rotary International in 1999. He also won the “Best CEO” award by Titans Global in the Business & Professional Services category in 2017 & proudly received the Chairman’s Award by Kenya Medical Association in 2004.
Mr. W. Gyude Moore
Panelist
W. Gyude Moore is a senior policy fellow at the Center for Global Development. He
previously served as Liberia’s Minister of Public Works with oversight over the construction and maintenance of public infrastructure from December 2014 to January 2018.
Prior to that role, Moore served as Deputy Chief of Staff to President Ellen Johnson-
Sirleaf and Head of the President’s Delivery Unit (PDU). As Head of the PDU, his team
monitored progress and drove delivery of the Public Sector Investment Program of
Liberia—a program of over $1 billion in road, power, port infrastructure, and social
programs in Liberia after the civil war. As one of the President’s trusted advisors, he
also played a crucial role in supporting President Sirleaf as Liberia responded to the
West Africa Ebola outbreak and shaped its post-Ebola outlook
At CGD, Moore’s research focus is around financing infrastructure in Africa and the
changing landscape of development finance on the continent. His research tracks the channels of private sources of finance, the rise of China and its expanding role in Africa, and Africa’s response to these changes. He currently serves on the Board of Advisors of the Master of Science in Foreign Service Program at Georgetown University. He holds a BS in Political Science from Berea College and an MS in Foreign Service from Georgetown University.
Dr. Feseha Woldu
Moderator
Feseha Woldu, MSc, Ph.D, appointed by three Mayors to serve as Senior Deputy Director, for Health Regulation and Licensing Administration (HRLA), in the District of Columbia Department of Health. Dr. Woldu is a seasoned public health administrator, with more than 13 years’ of experience working with various health professionals, health care facilities, clinicians, community-based organizations, and consumer groups. He brings a global perspective to his position and a commitment to use the latest technology and improved license processing and regulatory oversight systems at HRLA, to protect the health and safety of the District’s citizens and visitors. Dr. Woldu provides oversight and direction for the Department of Health, Health
Regulation and Licensing Administration, that delivers competent, transparent, effective and efficient services as HRLA provides licensure and regulatory oversight for health care professionals, health care facilities, food establishments, pharmacies and pharmaceutical services, radiation emitting devises, animal disease control and prevention, and rodent control.
His special areas of interest include Adverse Event reporting, and the SafeRx and AccessRx programs in District of Columbia. As the Senior Deputy Director, Dr. Woldu works to create a licensing and regulatory system able to contribute to the quality of care in the District, to ensure that qualified health care professionals practice in accordance with best practices throughout the District’s health care facilities.
Dr. Woldu received his Ph.D. in Medicinal Chemistry from Howard University, master’s degree in Physical Chemistry from American University, and completed the Strategic Management of Regulatory and Enforcement Agencies program at Harvard University’s John F. Kennedy School of Government. He is commissioned as an officer of the Department of Health and Human Services under authority conferred by section 702(a) of the Federal Food, Drug, and Cosmetic Act, to conduct specifically authorized activities in designated program area in the District of Columbia.
Dr. Feseha Woldu
Moderator
Feseha Woldu, MSc, Ph.D, appointed by three Mayors to serve as Senior Deputy Director, for Health Regulation and Licensing Administration (HRLA), in the District of Columbia Department of Health. Dr. Woldu is a seasoned public health administrator, with more than 13 years’ of experience working with various health professionals, health care facilities, clinicians, community-based organizations, and consumer groups. He brings a global perspective to his position and a commitment to use the latest technology and improved license processing and regulatory oversight systems at HRLA, to protect the health and safety of the District’s citizens and visitors. Dr. Woldu provides oversight and direction for the Department of Health, Health
Regulation and Licensing Administration, that delivers competent, transparent, effective and efficient services as HRLA provides licensure and regulatory oversight for health care professionals, health care facilities, food establishments, pharmacies and pharmaceutical services, radiation emitting devises, animal disease control and prevention, and rodent control.
His special areas of interest include Adverse Event reporting, and the SafeRx and AccessRx programs in District of Columbia. As the Senior Deputy Director, Dr. Woldu works to create a licensing and regulatory system able to contribute to the quality of care in the District, to ensure that qualified health care professionals practice in accordance with best practices throughout the District’s health care facilities.
Dr. Woldu received his Ph.D. in Medicinal Chemistry from Howard University, master’s degree in Physical Chemistry from American University, and completed the Strategic Management of Regulatory and Enforcement Agencies program at Harvard University’s John F. Kennedy School of Government. He is commissioned as an officer of the Department of Health and Human Services under authority conferred by section 702(a) of the Federal Food, Drug, and Cosmetic Act, to conduct specifically authorized activities in designated program area in the District of Columbia.
Dr. Feseha Woldu
Moderator
Feseha Woldu, MSc, Ph.D, appointed by three Mayors to serve as Senior Deputy Director, for Health Regulation and Licensing Administration (HRLA), in the District of Columbia Department of Health. Dr. Woldu is a seasoned public health administrator, with more than 13 years’ of experience working with various health professionals, health care facilities, clinicians, community-based organizations, and consumer groups. He brings a global perspective to his position and a commitment to use the latest technology and improved license processing and regulatory oversight systems at HRLA, to protect the health and safety of the District’s citizens and visitors. Dr. Woldu provides oversight and direction for the Department of Health, Health
Regulation and Licensing Administration, that delivers competent, transparent, effective and efficient services as HRLA provides licensure and regulatory oversight for health care professionals, health care facilities, food establishments, pharmacies and pharmaceutical services, radiation emitting devises, animal disease control and prevention, and rodent control.
His special areas of interest include Adverse Event reporting, and the SafeRx and AccessRx programs in District of Columbia. As the Senior Deputy Director, Dr. Woldu works to create a licensing and regulatory system able to contribute to the quality of care in the District, to ensure that qualified health care professionals practice in accordance with best practices throughout the District’s health care facilities.
Dr. Woldu received his Ph.D. in Medicinal Chemistry from Howard University, master’s degree in Physical Chemistry from American University, and completed the Strategic Management of Regulatory and Enforcement Agencies program at Harvard University’s John F. Kennedy School of Government. He is commissioned as an officer of the Department of Health and Human Services under authority conferred by section 702(a) of the Federal Food, Drug, and Cosmetic Act, to conduct specifically authorized activities in designated program area in the District of Columbia.
Dr. Feseha Woldu
Moderator
Feseha Woldu, MSc, Ph.D, appointed by three Mayors to serve as Senior Deputy Director, for Health Regulation and Licensing Administration (HRLA), in the District of Columbia Department of Health. Dr. Woldu is a seasoned public health administrator, with more than 13 years’ of experience working with various health professionals, health care facilities, clinicians, community-based organizations, and consumer groups. He brings a global perspective to his position and a commitment to use the latest technology and improved license processing and regulatory oversight systems at HRLA, to protect the health and safety of the District’s citizens and visitors. Dr. Woldu provides oversight and direction for the Department of Health, Health
Regulation and Licensing Administration, that delivers competent, transparent, effective and efficient services as HRLA provides licensure and regulatory oversight for health care professionals, health care facilities, food establishments, pharmacies and pharmaceutical services, radiation emitting devises, animal disease control and prevention, and rodent control.
His special areas of interest include Adverse Event reporting, and the SafeRx and AccessRx programs in District of Columbia. As the Senior Deputy Director, Dr. Woldu works to create a licensing and regulatory system able to contribute to the quality of care in the District, to ensure that qualified health care professionals practice in accordance with best practices throughout the District’s health care facilities.
Dr. Woldu received his Ph.D. in Medicinal Chemistry from Howard University, master’s degree in Physical Chemistry from American University, and completed the Strategic Management of Regulatory and Enforcement Agencies program at Harvard University’s John F. Kennedy School of Government. He is commissioned as an officer of the Department of Health and Human Services under authority conferred by section 702(a) of the Federal Food, Drug, and Cosmetic Act, to conduct specifically authorized activities in designated program area in the District of Columbia.
Hôtes
Anadach Group LLC est une société de conseil stratégique en soins de santé qui se concentre sur la fourniture de conseils et de services innovants aux clients et partenaires intéressés par la transformation des systèmes de santé dans les marchés émergents et les économies en développement. Notre mission est d'améliorer considérablement l'accès à des services et produits de santé de qualité dans les pays émergents en améliorant les solutions aux défis majeurs auxquels sont confrontés les soins de santé.
People to People (P2P) est une organisation non gouvernementale à but non lucratif dédiée à l'amélioration des soins de santé et à la réduction de la propagation des maladies, en particulier en Éthiopie et dans les communautés de la diaspora. P2P s'efforce de mobiliser la diaspora éthiopienne mondiale pour qu'elle joue un rôle actif dans l'atténuation de l'impact de la fuite des cerveaux et pour susciter une passion pour la réalisation de notre responsabilité partagée de redonner. Doté d'idées innovantes, de précieux réseaux transnationaux, de connaissances et d'expertise, de valeurs fortes et de nouvelles compétences technologiques, notre réseau est prêt à relever de nombreux défis auxquels sont confrontées les communautés et les institutions en Éthiopie et ailleurs. Il y a actuellement plus de 5 000 membres P2P dans le monde, y compris des médecins et d'autres professionnels qui s'efforcent de faire une différence dans la vie des autres. P2P détient également le statut consultatif auprès du Conseil économique et social des Nations Unies (UNESCO).